Sagimet Biosciences, Inc. (SGMT)
7.97
-0.06
(-0.75%)
USD |
NASDAQ |
May 01, 11:20
Sagimet Biosciences EPS Diluted (Quarterly) : -0.2942 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Omeros Corp. | 0.9771 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.568M |
| Total Expenses (Quarterly) | 9.568M |
| Enterprise Value | 145.48M |
| Earnings Yield | -19.81% |
| Normalized Earnings Yield | -19.81 |